l Liquid ventilation with perfluorocarbon (PFCV) has advantages over conventional gas ventilation (GV) in premature and lung-injured newborn animals. Indirect calorimetric measurement of both oxygen consumption (\iO,) and carbon dioxide production (\iCO,) during PFCV has not been previously performed. In addition, comparison to indirect calorimetric measurement of \iO, and \jCOz during GV has not been evaluated. Ten fasted normal cats weighing 2.6 to 3.9 kg were anesthetized with pentobarbital and pancuronium. Tracheostomy was performed. Gas exchange was measured across the native lung during GV and across the membrane lung of the liquid ventilator during PFCV. \j02 was measured using a modification of a previously described, indirect, closed-circuit, volumetric technique. \jCOz was analyzed by capnographic assay of the mixed-expired closed-circuit air. in the PFC-filled lung with associated improvement in compliance, improvement in ventilation/perfusion matching, and reduction in ventilator airway pressure requirements.6-9 Although the goal of PFCV is to provide .gas exchange, few studies have actually measured VO-, and VC02 during liquid ventilation.xJO.l' Those that have evaIuated gas exchange during PFCV indicate that there is a reduction in the metabolic rate, the etiology of which remains unclear. In these studies, VOz and/or VCOz during gas and liquid ventilation were compared in different animals, under different conditions, or by methods with potential for significant measurement inaccuracy. The purpose of this study, therefore, is to relate gas exchange in comparison during PFCV and gas ventilation (GV) in the same animals under the same conditions by an indirect, calorimetric. technique which allows accurate measurement of VO? and VCO1."J"
in the PFC-filled lung with associated improvement in compliance, improvement in ventilation/perfusion matching, and reduction in ventilator airway pressure requirements. [6] [7] [8] [9] Although the goal of PFCV is to provide .gas exchange, few studies have actually measured VO-, and VC02 during liquid ventilation.xJO.l' Those that have evaIuated gas exchange during PFCV indicate that there is a reduction in the metabolic rate, the etiology of which remains unclear. In these studies, VOz and/or VCOz during gas and liquid ventilation were compared in different animals, under different conditions, or by methods with potential for significant measurement inaccuracy. The purpose of this study, therefore, is to relate gas exchange in comparison during PFCV and gas ventilation (GV) in the same animals under the same conditions by an indirect, calorimetric. technique which allows accurate measurement of VO? and VCO1."J"
MATERIALS AND METHODS
Ten healthy cats weighing 2.6 to 3.0 kg were anesthetized with pentobarbital, 25 mgikg. A midline neck incision was performed and the trachea as well as the right carotid artery and internal jugular vein were isolated. A tracheostomy tube was advanced into the trachea to a point above the carina and anchored in place. A jet ventilation endotracheal tube (Mallinckrodt, Inc, Argyle, NY) was utilized in order to allow measurement of carinal airway pressure. An IS-gauge catheter was placed in the carotid artery and a 4F INDEX WORDS: Liquid ventilation. P ULMONARY gas exchange utilizing perfluorocarbon liquid ventilation (PFCV) has been investigated over the past 25 years.'v4 Efficacy of gas exchange in normal animals has been established. 5 In addition, numerous studies in newborn premature animals have demonstrated efficacy in providing reduction of surface tension at the air-liquid interface 
Measurement of ?Oz and IkO,
A previously described device was adapted as a flow-limited, time cycled ventilator which allowed measurement of VOz and VCOz during gas ventilation (Fig 1) .r3 This device consists of a Cobe occlusive roller pump (Cobe Cardiovascular, Inc, Arvada, CO), which induces continuous gas flow at a prescribed rate through a closed circuit. The roller pump, the endotracheal tube, and a pinch valve are connected in series. A controller box allows alteration in inspiratory (IT) and expiratory time (ET) through variation of the duration of pinch valve closure. Tidal volume (TV), therefore, is dependent on gas flow rate (GFR) and inspiratory time. The appropriate gas flow rate for each desired number of breaths per minute, inspiratory and expiratory times, and desired tidal volume may be calculated using the equation: 
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PaCOz at onset of GV. Anesthesia was administered by continuous infusion of pentobarbital, 10 mgikg, throughout each study. Arterial blood gas data were assessed utilizing an ABL 30 Blood Gas Analyzer (Radiometer A/S, Copenhagen, Denmark). Blood oxygen saturation data were evaluated using an OSM 3 co-oximeter (Radiometer A/S).
Data Analysis
Membrane GO? and GCOz data collected during each of the lo-minute periods were averaged and ?SD determined for GV and PFCV for all animals. Arterial blood gas data collected from all animals after 1 houf of either GV or PFCV were averaged and +SD determined. The VCOJVO2 ratio (RQ) was calculated, averaged, and *SD determined for GV and PFCV. The paired Student's t test was applied for statistical comparison of data.
Approval for this study was obtained from the committee on university laboratory animal medicine at the University of Michigan Medical Center and all animal care guidelines followed. Animals were euthanized at completion of the study.
RESULTS
tube. A pinch valve is present on the expiratory limb followed in series by a reservoir, a roller pump, a membrane lung, and a heat exchanger.
A controller box induces pinch valve closure simultaneously with onset of roller pump function during inspiration. This provides occlusion of the expiratory limb during inspiration as perfluorocarbon is perfused through the membrane lung and heat exchanger and a pulmonary tidal volume is produced. During expiration, roller pump activity is discontinued which provides occlusion of the inspiratory limb as the pinch valve opens allowing drainage of perfluorocarbon from the lungs into the reservoir. Animals were hyperoxygenated and hyperventilated prior to institution of liquid ventilation. Warmed, oxygenated PFC (Rimar-101. density 1.76 g/mL, Miteni SPA, Milano, Italy) 35 mL/kg was then instilled into the endotracheal tube (En) and the lungs debubbled. The E'IT was then attached to the liquid ventilator and PFCV performed.
After liquid ventilation was instituted the membrane lung was incorporated into the device used for measurement of 0: consumption and CO1 production as described above (Fig 2) . This allowed measurement of qOZ and CC02 during liquid ventilation.
Arterial blood gas data (Fig 5) after 1 Fig 61) .
Measurement of Gas Exchange
Once stable after performance of tracheostomy and line placement, the animal was placed on the gas ventilator described previously.
GO? was then assessed over three consecutive lominute periods. Capnometric data were collected at the end of each of the three lo-minute periods. Liquid ventilation was then instituted as described above. Once stable on the liquid ventilator, the membrane lung was incorporated into the gas exchange measurement device. VOz and VCO2 data were then collected, as during GV, over three consecutive lo-minute periods.
Pancuronium bromide, 0.1 mgikg, was administered immediately prior to each series of gas exchange measurements during GV and liquid ventilation in order to provide pharmacological paralysis. Rectal temperature was maintained at 37S"C ? O.S'C at all times. The PaC02 was maintained at ?lO mm Hg from the original 
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DISCUSSION
This study documents that oxygen consumption and carbon dioxide production remain unchanged during liquid ventilation when related in comparison to that during GV. In addition, provision of adequate gas exchange utilizing PFCV in normal animals is demonstrated.
The concept of liquid ventilation extends back to the early 1920s when the efficacy of saline as a means of altering the physiologic effects of the pulmonary gas-liquid interface was investigated.5 However, because of the limited solubility of oxygen in saline (approximately 2 mL OJdL at PO1 = 700 mm Hg), adequate oxygenation could not be provided during 
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saline liquid ventilation except under hyperbaric conditions.i5 Interest in the pulmonary apphcations of perfluorocarbon liquids, which incorporated properties of low surface tension and high oxygen solubility, began in 1966.' At that time, the ability of the perfluourocarbon FX-80 to provide adequate gas exchange in the spontaneously breathing mouse and cat was demonstrated. Since then, a variety of perfluorocarbons have been developed and used, with the most recent generation incorporating and enhancing such desirable properties as low surface tension, high gas solubility, low viscosity to decrease airway resistance, and relatively high vapor pressure so that the perfluorocarbon might evaporate from the airways after conversion from liquid to gas ventilation.16 Subsequent studies have demonstrated improved survival, enhanced gas exchange, and increased compliance in premature newborn animals, full-term lambs with meconium aspiration, and in animals with experimentally induced lung injury.sJ7J8 In addition, the first human trials of liquid ventilation in three neonates have demonstrated feasibility of gas exchange utilizing liquid ventilation.r9
Although the efficacy of gas exchange during liquid ventilation has been assessed in numerous studies, measurement of VOZ and VC02 has rarely been evaluated. Among the studies that have investigated gas exchange during perfluorocarbon ventilation include those by Sivieri et al'" in 1981 and Harris et al" in 1983. In the former, VO? in spontaneously gasbreathing animals was compared to that during liquid ventilation as measured by a spirometric, volume-loss technique similar to the method utilized in this study. V02 was found to decrease 18.6% after initiation of liquid ventilation. In the second study, Harris et al evaluated VOZ and VC02 in animals undergoing liquid ventilation by measuring the oxygen tension in inspired (P,O,) and expired (PE02) PFC and the carbon dioxide tension in inspired (PIC02) and expired (PECOZ) PFC and calculating gas exchange based on the following equations: Voz = v, (Pi02 -(PEOZ) * mo, VCOZ = VE (P&O2 -P,COJ * aCOz where aOz and aCOz are the solubility coefficients for oxygen and carbon dioxide, respectively, in PFC and VE is the minute volume ventilation with PFC. The derived values of VOZ and VC02 were then compared to values obtained in similar fashion from another group of animals during GV. VO? and VCOZ were reduced in this study after application of liquid ventilation by 42% and 35%, respectively. Therefore, in both of these studies, gas exchange appeared to be reduced during liquid ventilation, although the under-lying physiology accounting for this finding remained unclear.
In the current study, gas exchange during liquid ventilation remained unchanged in comparison to that noted during GV. We believe that our study differ! from those of others for the following reasons:
1. VO? and VCO, were evaluated by methods which allowed accurate measurement of gas exchange. In the study by Harris et al, evaluation of gas exchange was based on measurements of oxygen and carbon dioxide tensions in inspired and expired perfluorocarbon in order to calculate GO1 and cCO1. The authors, in discussing their results, note that the calculations for VOZ and QCO, are dependent on solubility coefficients for these gases in PFC and that a variety of differing solubility coefficients have been determined, which may induce up to a 20% to 30% variation depending on the coefficient used. In contrast, the present study used an indirect, closed-circuit calorimetric technique that allowed accurate measurement of VOZ and VCO? without need for application of a gas solubility coefficient. 2. in the study by Sivieri et al, animals were spontaneously respiring during gas breathing, but were pharmacologically paralyzed and ventilated during liquid breathing. In normal animals, the resting energy expenditure from breathing is approximately 1% to 5% of overall oxygen consumption and is even greater during periods of hyperventilation.'0 In addition, pharmacological paralysis may result in an 11% reduction in VO'." Mechanical ventilation and pharmacological paralysis, therefore, could account for the reduction in oxygen consumption noted in the study by Sivieri et al. In contrast, in the present study, animals were pharmacologically paralyzed and mechanically ventilated when gas exchange measurements were performed during both GV and PFCV. The accuracy of the closed-circuit, indirect calorimetric technique for evaluating VOz and VCO? has been previously documented.12J" The efficacy of a modification of this technique for the measurement 517 of gas exchange during liquid ventilation has been demonstrated in this study. A number of factors, however,.may affect the metabolic rate or the measurement of V02 and VC02. For instance:
Gas exchange could potentially have been altered because of variation in the PaCOz and pH. The metabolic rate has been shown to increase with a rising pH and diminishing PaCO>. This change in VOz has been demonstrated to increase approximately 7% for each 10 mm Hg decrease in PaCO 2.22 PaCO? values during this study were, therefore, maintained at -+lO mm Hg from the initial PaCO?. The metabolic rate may be altered with temperature, level of sedation, and paralysis. Therefore, all of these were carefully controlled throughout this s.fudy. Stability of the VCO? and PaGO? are required fpr accurate assessment of VCO?. However, VCO,, as measured by the method used in this study, would not have been affected by the absolute PaCO? value as long as that value was relatively stable. A stable PaCO, (k5 mm Hg between gas exchange measurements) was ensured during all measurements of VCO?. Therefore, any differences in PaCO? seen between gas and liquid ventilation would not have affected the measured kO1. Excellent gas exchange capabilities were documented during perfluorocarbon ventilation. The slight, but significant, reduction in the PaOz during PFCV when compared to GV is expected because of the relative reduction in inspiratory partial pressure of oxygen in PFC (PiO,(,,,, ) during liquid ventilation (Pi02(ptcc) = 380 k 102 mm Hg) in comparison to the PiO. of the closed circuit during GV (FiOz = 1.0, PiO, = approximately 700 mm Hg). If adequate time is allowed, the partial pressure of oxygen in PFC will equilibrate with the partial pressure of oxygen in the gas to which the PFC is exposed. Therefore, this reduction in PiOZ(pfcj and Pa03 is a reflection of minor limitations in the liquid ventilator device utilized, rather than being inherent to the liquid ventilation technique itself. Liquid ventilation with the use of perfluorcarbons has been studied for the past 25 years. Recent advances in the development of these compounds takes advantage of the low surface tension, high gas solubility, and low viscosity allowing delivery of oxygen and elimination of CO? in a low-pressure system. Animal models using liquid ventilation to treat meconium aspiration and other experimental lung injuries have noted increased compliance, enhanced gas exchange, and improved survival. Liquid ventilation has also been shown to extend the limits of viability of immature lambs presumably by eliminating the dependency on surfactant. The recent initial human studies have demonstrated the feasibility of the model in premature babies. However, the very viable nature of the initial subjects that being a pH of 6.77 to 7.22 and short term survival and 19 hours at the maximum prevents determination of therapeutic benefits. Dr Hirsch1 and his colleagues have made a significant contribution to the field of liquid ventilation. They have demonstrated the efficacy of measuring oxygen consumption and carbon dioxide production during liquid ventilation using an indirect calorometic technique. They have shown that oxygen consumption and CO? production do not change during liquid ventilation and that excellent gas exchange can be accomplished due to fluorocarbon ventilation. My questions are as follows. In your model, the inspiratory partial pressure of oxygen in PFCV was 380 & 102 mm Hg compared to approximately 700 mm Hg in the GV system. I understand from the manuscript that this is limited by your present system. Therefore, do you have plans to change your system to allow a higher partial pressure of oxygen in perfluorocarbon? Second, what do you foresee as the clinical application of this therapy? Will it be limited initially to prematures as in the initial clinical trial? Will it increase the viability of the fetus to a lower gestational age? Could this modality be used in the older infants and children with acute insults such as inhalation injuries and severe respiratory distress of other causes? And, finally, how can you avoid the situation experienced by other new therapies in which only the sickest and probably unsalvageable children are offered the new therapy. This appears to be the situation in the initial clinical trial. What do you foresee as the future for this modality?
W.J. Chwals (Winston-Salem, NC): Hirschl, in as much as the difference between ventilation conventionally and PFCV may be due to a difference in muscle tone in terms of energy expenditure, is the fact that your model involved paralysis not likely to reduce any differences which may be seen in conventional ventilation versus the PFCV model? In previous studies, the ventilatory mode when conventional ventilation was used is seldom complemented by paralysis.
